374 related articles for article (PubMed ID: 30507624)
1. Molecular characterization of endometrial cancer and therapeutic implications.
Chang Z; Talukdar S; Mullany SA; Winterhoff B
Curr Opin Obstet Gynecol; 2019 Feb; 31(1):24-30. PubMed ID: 30507624
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of endometrial cancer and therapeutic implications.
Winterhoff B; Thomaier L; Mullany S; Powell MA
Curr Opin Obstet Gynecol; 2020 Feb; 32(1):76-83. PubMed ID: 31851045
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of endometrial cancer and therapeutic implications.
Uppendahl L; Mullany SA; Winterhoff B
Curr Opin Obstet Gynecol; 2017 Feb; 29(1):35-39. PubMed ID: 27941362
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive genomic profiling of recurrent endometrial cancer: Implications for selection of systemic therapy.
Prendergast EN; Holman LL; Liu AY; Lai TS; Campos MP; Fahey JN; Wang X; Abdelaal N; Rao JY; Elvin JA; Moore KM; Konecny GE; Cohen JG
Gynecol Oncol; 2019 Sep; 154(3):461-466. PubMed ID: 31257009
[TBL] [Abstract][Full Text] [Related]
5. The emerging genomic landscape of endometrial cancer.
Le Gallo M; Bell DW
Clin Chem; 2014 Jan; 60(1):98-110. PubMed ID: 24170611
[TBL] [Abstract][Full Text] [Related]
6. Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts.
Stelloo E; Nout RA; Osse EM; Jürgenliemk-Schulz IJ; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Nijman HW; Putter H; Bosse T; Creutzberg CL; Smit VT
Clin Cancer Res; 2016 Aug; 22(16):4215-24. PubMed ID: 27006490
[TBL] [Abstract][Full Text] [Related]
7. Classification of Endometrial Carcinoma: New Perspectives Beyond Morphology.
Akhtar M; Al Hyassat S; Elaiwy O; Rashid S; Al-Nabet ADMH
Adv Anat Pathol; 2019 Nov; 26(6):421-427. PubMed ID: 31567131
[TBL] [Abstract][Full Text] [Related]
8. Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression.
Ashley CW; Da Cruz Paula A; Kumar R; Mandelker D; Pei X; Riaz N; Reis-Filho JS; Weigelt B
Gynecol Oncol; 2019 Jan; 152(1):11-19. PubMed ID: 30415991
[TBL] [Abstract][Full Text] [Related]
9. Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.
Talhouk A; McConechy MK; Leung S; Yang W; Lum A; Senz J; Boyd N; Pike J; Anglesio M; Kwon JS; Karnezis AN; Huntsman DG; Gilks CB; McAlpine JN
Cancer; 2017 Mar; 123(5):802-813. PubMed ID: 28061006
[TBL] [Abstract][Full Text] [Related]
10. A Timely Update of Immunohistochemistry and Molecular Classification in the Diagnosis and Risk Assessment of Endometrial Carcinomas.
Wang M; Hui P
Arch Pathol Lab Med; 2021 Nov; 145(11):1367-1378. PubMed ID: 34673912
[TBL] [Abstract][Full Text] [Related]
11. Treatment options for molecular subtypes of endometrial cancer in 2023.
Karpel HC; Slomovitz B; Coleman RL; Pothuri B
Curr Opin Obstet Gynecol; 2023 Jun; 35(3):270-278. PubMed ID: 36943683
[TBL] [Abstract][Full Text] [Related]
12. Reclassifying endometrial carcinomas with a combined morphological and molecular approach.
Carlson J; McCluggage WG
Curr Opin Oncol; 2019 Sep; 31(5):411-419. PubMed ID: 31261170
[TBL] [Abstract][Full Text] [Related]
13. Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators.
An HJ; Kim KI; Kim JY; Shim JY; Kang H; Kim TH; Kim JK; Jeong JK; Lee SY; Kim SJ
Am J Surg Pathol; 2007 Jun; 31(6):846-53. PubMed ID: 17527071
[TBL] [Abstract][Full Text] [Related]
14. The Genomic Heterogeneity of FIGO Grade 3 Endometrioid Carcinoma Impacts Diagnostic Accuracy and Reproducibility.
Hussein YR; Broaddus R; Weigelt B; Levine DA; Soslow RA
Int J Gynecol Pathol; 2016 Jan; 35(1):16-24. PubMed ID: 26166718
[TBL] [Abstract][Full Text] [Related]
15. Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative.
Stelloo E; Bosse T; Nout RA; MacKay HJ; Church DN; Nijman HW; Leary A; Edmondson RJ; Powell ME; Crosbie EJ; Kitchener HC; Mileshkin L; Pollock PM; Smit VT; Creutzberg CL
Mod Pathol; 2015 Jun; 28(6):836-44. PubMed ID: 25720322
[TBL] [Abstract][Full Text] [Related]
16. Interobserver Agreement in Endometrial Carcinoma Histotype Diagnosis Varies Depending on The Cancer Genome Atlas (TCGA)-based Molecular Subgroup.
Hoang LN; Kinloch MA; Leo JM; Grondin K; Lee CH; Ewanowich C; Köbel M; Cheng A; Talhouk A; McConechy M; Huntsman DG; McAlpine JN; Soslow RA; Gilks CB
Am J Surg Pathol; 2017 Feb; 41(2):245-252. PubMed ID: 28079598
[TBL] [Abstract][Full Text] [Related]
17. TCGA Classification of Endometrial Cancer: the Place of Carcinosarcoma.
Travaglino A; Raffone A; Gencarelli A; Mollo A; Guida M; Insabato L; Santoro A; Zannoni GF; Zullo F
Pathol Oncol Res; 2020 Oct; 26(4):2067-2073. PubMed ID: 32472441
[TBL] [Abstract][Full Text] [Related]
18. The genetic landscape of endometrial clear cell carcinomas.
DeLair DF; Burke KA; Selenica P; Lim RS; Scott SN; Middha S; Mohanty AS; Cheng DT; Berger MF; Soslow RA; Weigelt B
J Pathol; 2017 Oct; 243(2):230-241. PubMed ID: 28718916
[TBL] [Abstract][Full Text] [Related]
19. [Current prerequisites for a molecular genetic classification of endometrial cancer].
Vtorushin SV; Malykh RD
Arkh Patol; 2017; 79(3):57-62. PubMed ID: 28631718
[TBL] [Abstract][Full Text] [Related]
20. Biomarker-driven therapy in endometrial cancer.
Karpel H; Slomovitz B; Coleman RL; Pothuri B
Int J Gynecol Cancer; 2023 Mar; 33(3):343-350. PubMed ID: 36878569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]